{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.560","meta":{"versionId":"11","lastUpdated":"2021-03-06T01:00:18.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.560","version":"20210306","name":"Rolapitant Oral","status":"active","date":"2021-03-06T01:00:18-05:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"1665503","display":"rolapitant 90 MG Oral Tablet"}]}]},"expansion":{"identifier":"urn:uuid:c8854240-eaa4-450f-b87f-b33ebde2b56a","timestamp":"2022-06-10T11:42:59-04:00","total":1,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1665503","display":"rolapitant 90 MG Oral Tablet"}]}}